ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs

NCT05270135 | Completed

• 1 other identifier: 2011214920
• Study Type: interventional
• Target: 18
• Locations: 1 country
• Sites: 1

Brief Summary

Access to Syringes at Pharmacies (ASAP) is a refinement of an evidence-based, pharmacy intervention to increase pharmacy-based sales of syringes to PWID in order to reduce bloodborne illnesses among them.

Conditions

Skin and Soft Tissue Infections; Hiv; Hepatitis C; Bloodstream Infection

Outcome Measures

Primary Outcomes (2)

• Syringe sales increase as measured by the sales tracking instrument

  ASAP pharmacies will increase the sale of nonprescription syringes upon request

  by end of year 2

• Reduced stigma as measured by the feasibility assessment tool

  ASAP pharmacy staff will report a reduction in expressed stigma at the time of syringe sales.

  by end of year 2

Study Arms (1)

ASAP Intervention

OTHER

This is a pilot study of the ASAP intervention pharmacies to explore the preliminary impact of intervention components: the CEU training, coaching from research staff, ASAP materials and tracking for the sale of syringes. Staff of each enrolled pharmacy will complete surveys.

Behavioral: ASAP

Interventions

ASAP BEHAVIORAL

ASAP is an intervention geared toward increasing non-stigmatized syringe sales to people who inject drugs to prevent bloodborne illnesses.

ASAP Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• full time pharmacy staff member as a pharmacist or a pharmacy technician in an Arizona pharmacy within the three study counties (Pima, Maricopa, Mohave)

You may not qualify if:

• not a full time pharmacy staff member

Sponsors & Collaborators

• University of Arizona: lead

Study Sites (1)

University of Arizona College of Medicine

Tucson, Arizona, 85714, United States

Location

MeSH Terms

Conditions

Soft Tissue Infections; Acquired Immunodeficiency Syndrome; Hepatitis C; Sepsis

Condition Hierarchy (Ancestors)

Infections; HIV Infections; Blood-Borne Infections; Communicable Diseases; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Slow Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases; Hepatitis, Viral, Human; Flaviviridae Infections; Hepatitis; Liver Diseases; Digestive System Diseases; Systemic Inflammatory Response Syndrome; Inflammation; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Pilot study of an intervention using one group comprised of three pharmacies and their enrolled staff.

Study Record Dates

• First Submitted: February 15, 2022
• First Posted: March 8, 2022
• Study Start: December 1, 2022
• Primary Completion: June 30, 2023
• Study Completion: September 30, 2023
• Last Updated: December 19, 2023

Record last verified: 2023-12

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)